RecruitingNot ApplicableNCT05742880

Effect of Face Masks on Pulmonary Function in Patients With COPD

Sponsor

Medical University of Vienna

Enrollment

40 participants

Start Date

Nov 1, 2022

Study Type

INTERVENTIONAL

Conditions

COPD Walking, Difficulty

Summary

Given the heightened vulnerability of COPD patients to severe illness upon SARS-CoV-2 infection, precautions like mask-wearing are deemed crucial. Yet, mask-wearing can exacerbate breathlessness and discomfort in this demographic. This study aims to assess the effects of wearing a face mask during 6-Minute-Walking-Tests (6-MWT) among COPD patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the effects of wearing face masks on lung function in people with COPD (a chronic lung disease that makes breathing difficult). As mask-wearing became common during the COVID-19 pandemic, researchers want to understand if masks pose any additional breathing burden for COPD patients. **You may be eligible if...** - You have been diagnosed with COPD - You have been vaccinated against SARS-CoV-2 (COVID-19) **You may NOT be eligible if...** - You have known heart failure - You require long-term oxygen therapy - You have limited mobility (immobility) - Your BMI is above 35 - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.